Vaccines, blood, antisera, toxins and cultures in   Lithuania

Exports In 2022, Lithuania exported $256M in Vaccines, blood, antisera, toxins and cultures, making it the 32nd largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 36th most exported product in Lithuania. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Lithuania are: Belarus ($47.6M), United States ($36.3M), Israel ($26.5M), Russia ($26.4M), and Netherlands ($22.3M).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Lithuania between 2021 and 2022 were Belarus ($20.5M), Israel ($20.3M), and Netherlands ($15.3M).

Imports In 2022, Lithuania imported $341M in Vaccines, blood, antisera, toxins and cultures, becoming the 62nd largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 16th most imported product in Lithuania. Lithuania imports Vaccines, blood, antisera, toxins and cultures primarily from: Germany ($95.8M), Belgium ($53.6M), Netherlands ($32.4M), Poland ($25.2M), and Slovenia ($24M).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Lithuania between 2021 and 2022 were Slovenia ($22.6M), Poland ($5.55M), and Sweden ($4.01M).